feed,title,long_url,short_url
Investors,"Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating",https://www.investors.com/news/technology/halozyme-therapeutics-stock-earns-ibd-stock-rating-upgrade-hitting-80-plus-rs-rating-2/,https://da.gd/o1Xvn
Investors,Agilysys Stock Moving Up The Leadership Ladder; Earns 81 RS Rating,https://www.investors.com/news/technology/agilysys-stock-moving-up-the-leadership-ladder-earns-81-rs-rating/,https://da.gd/rqBgzF
Investors,Salesforce Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark,https://www.investors.com/news/technology/salesforce-stock-earns-relative-strength-rating-upgrade-hits-key-benchmark/,https://da.gd/W2wKr7
